リリベット カジノ用初回入金ボーナス

<ウェブサイト名>

<現在の時刻>

出典: 標準

MENU 公司信息 公司信息 返回 公司信息 领导致辞 创业精神 品牌宣言 沿革 价值创造的历史 愿景与战略体系 集团的愿景 长期经营战略(英语) 经营方针(英语) 中期经营计划(英语) 公司简介与事业据点 事业简介(英语) 董事介绍 公司治理(英语) 集团公司 采购方针 内部管控的基本方针(英语) 综合报告(英语) 产品与技术 产品信息 返回 产品信息 按用途检索 智能移动 建筑材料 基础设施与一般产业 电子 半导体 能源 生活用品、食品产业 生命科学 按事业内容检索 建筑玻璃 汽车 显示器玻璃 电子材料 基础化学品 高性能化学品 生命科学 工业陶瓷 新事业 按名称检索 按关键词检索 技术开发与创新 返回 技术开发与创新 CTO致辞(英语) 技术开发战略(英语) 知识产权战略(英语) 研究开发体制(英语) 核心技术(英语) Technology Highlights(英语) 智能移动(英语) 电子(英语) 生命科学(英语) AGC横滨技术中心(英语) 协创空间“AO” (英语) 简介(英语) 设施介绍(英语) 交通路线(英语) 协创案例(英语) 合作研究制度(英语) 研发资料库(英语) 公共研究费(英语) 可持续发展 可持续发展 返回 可持续发展 守护地球环境,充分利用资源(英语) 支持城市和智能移动的发展(英语) 实现可健康生活的长寿社会(英语) 携手共创健全、安心的社会(英语) 从安全、公平的职场中产生新的价值(英语) 领导致辞(英语) AGC集团的可持续发展经营(英语) 可持续发展推进体制(英语) 报告书下载(英语) 现场报告(英语) 外界评价(英语) GRI标准对照表(英语) 可持续发展相关方针、标准、指南等(英语) 下载行动准则 股东·投资者信息 股东·投资者信息 返回 股东·投资者信息 经营信息(英语) 面向股东(英语) 愿景与战略体系 事业风险(英语) 信息公开准则(英语) 业绩摘要(英语) IR新闻(英语) IR资料库(英语) 面向投资者的公司简介(英语) 财务业绩说明会资料(英语) 事业說明会资料(英语) 财报概要(英语) Financial Review(仅限英语) AGC Review(股东通信)(英语) ESG信息 可持续发展 公司治理(英语) 综合报告(英语) 股票和公司债券信息(英语) 股票信息(英语) 公司债券、评级信息(英语) 股息信息(英语) 分析师报道(英语) 股东大会(英语) 股票交易规则方法(英语) 电子公告(英语) 公司章程(英语) 股价信息(英语) 联系方式(英语) 常见问题(英语) 邮件订阅与投资者相关的新闻(英语) 帮助信息(英语) IR日历(英语) 免责条款(英语) IR网站地图 招聘 联系我们 CN JP EN 检索 生命科学 We are engaged in a global life science business, centering on contract development and manufacturing organization (CDMO) activities, where we develop manufacturing processes for and manufacture pharmaceutical and agrochemical components. Life Science Business Inquiry related to Life Science 生命科学 We are engaged in a global life science business, centering on contract development and manufacturing organization (CDMO) activities, where we develop manufacturing processes for and manufacture pharmaceutical and agrochemical components. Life Science Business Inquiry related to Life Science 按用途检索 按事业内容检索 按名称检索 Pharmaceuticals and Agrochemicals Specialty Chemicals Pharmaceuticals and Agrochemicals CDMO Services for Biopharmaceuticals and Cell&Gene Therapies Contract Development and Manufacturing Services for Biopharmaceuticals and Cell&Gene Therapies AGC is one of the very few global CDMO based principally in Japan, and has a global network of three regions in Japan, the US and Europe. We have a wide range of production capabilities from a variety of flexible single-use manufacturing scales to large-scale commercial capabilities using 20,000L stainless steel reactors. From research stage to commercial production, we offer efficient and flexible support to all phases of customers’ biopharmaceutical and Cell&Gene Therapy projects with our advanced technology and extensive experience. 产品名称 CDMO Services for Biopharmaceuticals and Cell&Gene Therapies 用途 Contract manufacturing / Process Development / Analytical Development / Cell Line Development for biologics expression 详细信息 Small Molecule Pharmaceuticals CDMO Services Contract development and manufacturing services (PMDA, FDA inspection experience) for pharmaceutical. Based on more the 40 years of experience in contract development and manufacturning of intermediates and APIs, AGC continues robust supply of the product with quality control in compleance with cGMP.AGC has extensive experience in general chemical reactions, halogenation reactions including fluorination, cryogenic reactions. 产品名称 Small Molecule Pharmaceuticals CDMO Services 用途 Contract manufacturing / Process Development / Analytical Development 详细信息 Agrochemicals CDMO Services Contract manufacturing on an industrial scale for agrochemical intermediates and active ingredients using an efficient development process AGC offers contract manufacturing services for agrochemical intermediates and active ingredients matched to customers’ needs using precision organic synthesis technology. With our efficient development process, we supply intermediates and active ingredients on an industrial scale. 产品名称 Agrochemicals CDMO Services 用途 Contract manufacturing / Process Development / Analytical Development 详细信息 Drug Discovery Businesses Drug discovery and creation of new drugs by joint development with pharmaceutical companies. AGC is engaged in discovery of compounds for drug and development of such compound with pharmaceutical companies, aiming to launch on the market. In 2008, we launched Tafluprost, a drug for glaucoma, which is jointly developed with Santen Pharmaceutical Co., Ltd.We are creating small molecular compounds which can be candidate for drug, mainly prostaglandin compounds, with a fusion of AGC’s fluorine chemistry and organic synthesis technology. 产品名称 Drug Discovery Businesses 用途 Drug Discovery 详细信息 Specialty Chemicals metallocene co-catalyst borate Ensure customer polymerization quality with high-quality borates with high purity and low moisture content High quality products with high purity and low moisture content ensure customer polymerization quality. In response to requests, it is also possible to control particle size and provide high-performance products with excellent solubility and suspensibility. 产品名称 metallocene co-catalyst borate 用途 Polyolefin polymerization / PE polymerization / EPDM manufacturing 详细信息 Trifluoroacetic Acid and Derivatives Available in 2 forms, 25 kg and 250 kg, depending on the customer's usage AGC sells trifluoroacetic acid, trifluoroacetic anhydride, and sodium trifluoroacetate, which are widely used in organic synthesis, pharmaceutical and pesticide manufacturing, and the electronics industry. 产品名称 Trifluoroacetic Acid and Derivatives 用途 Pharmaceuticals / Agrochemicals / Electronics / Organic Chesistry 详细信息 Propylene derivatives Strong support for customer manufacturing with C3 Chemical's technology, know-how, experience, and achievements cultivated over 50 years From our fundamental business of producing allyl chloride, which uses propylene (C3) as its basic raw material, epichlorohydrin, etc., we are developing our business into high value added C3 chemicals (functional products) synthesized as derivatives of propylene. 产品名称 C3 Chemicals 用途 Pharmaceutical / Agrochemical intermediates / Coating / Textile 详细信息 Specialty Chemicals CDMO Services Specialty chemicals CDMO services with efficient process development capabilities AGC provides CDMO services with organic synthesis process development capabilities cultivated through the pharmaceuticals and agrochemicals CDMO business, raw material procurement capabilities with the original global network, and manufacturing capabilities to achieve stable supply at low cost while continuing to pursue operational excellence. 产品名称 Specialty Chemicals CDMO Services 用途 Electronics / Coating / Cosmetics / Energy / Specialty chemicals / Organic compounds / Semiconductor / OLED 详细信息 主页产品信息生命科学 产品信息 按用途检索 智能移动 建筑材料 基础设施与一般产业 电子 半导体 能源 生活用品、食品产业 生命科学 按事业内容检索 建筑玻璃 汽车 显示器玻璃 电子材料 基础化学品 高性能化学品 生命科学 工业陶瓷 新事业 按名称检索 按关键词检索 Check in AGC 网站地图 关于社交媒体. 联系我们 关于本网站 个人信息保护对策 ©AGC Inc. ×

攻略型オンラインカジノ🌟カジノミー | 登録無料&豪華な新規特典 rizinブックメーカー オンラインカジノ特典 オリンピアコス試合
Copyright ©リリベット カジノ用初回入金ボーナス The Paper All rights reserved.